Unbound MEDLINE

Antimicrobial susceptibility and mutations involved in clarithromycin resistance in Helicobacter pylori, isolated from patients in the Colombian western central region. Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] Journal article

 
TitleAntimicrobial susceptibility and mutations involved in clarithromycin resistance in Helicobacter pylori, isolated from patients in the Colombian western central region.
Author(s)Alvarez A, Moncayo JI, Santacruz JJ, Santacoloma M, Corredor LF, Reinosa E 
InstitutionUniversidad Tecnológica de Pereira, Centro de Biología Molecular y Biotecnología, Laboratorio de Microbiología y Parasitología. Pereira - Colombia; Universidad de Caldas, Departamento Clínico Quirúrgico. Manizales - Colombia.
SourceAntimicrob Agents Chemother 2009 Jun 22.
AbstractIn a total of 106 H. pylori isolates, resistance to metronidazole, clarithromycin and amoxicillin was found in 82%, 3.8% and 1.9% of the isolates, respectively. No tetracycline-resistant isolates were found. In all clarithromycin-resistant isolates, only one point mutation was present, either A2143G or A2142G. Our results indicate that metronidazole should not be included in the empirical treatment of H. pylori infection in this region.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19546360
  
Advertise on this site.